Hsbc Holdings PLC Gossamer Bio, Inc. Transaction History
Hsbc Holdings PLC
- $176 Billion
- Q3 2025
A detailed history of Hsbc Holdings PLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 25,969 shares of GOSS stock, worth $70,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,969
Previous 18,066
43.75%
Holding current value
$70,375
Previous $22,000
209.09%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GOSS
# of Institutions
167Shares Held
157MCall Options Held
7.83MPut Options Held
179K-
Nea Management Company, LLC Timonium, MD18.1MShares$49 Million2.97% of portfolio
-
Octagon Capital Advisors LP New York, NY17.1MShares$46.2 Million14.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$32.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$21.8 Million9.24% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.13MShares$16.6 Million6.11% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $255M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...